Cardiff Oncology's total assets for Q3 2024 were $62.90M, a decrease of -4.78% from the previous quarter. DE:XE7C total liabilities were $13.50M for the fiscal quarter, a -1.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.